Smart Cancer Resources & Research Guide 2026: A Patient-First Map of Diagnosis, Biomarkers, Treatment, Immunotherapy, Resistance & Integrative Oncology
Cancer information is no longer confined to a single textbook, treatment guideline, or hospital website — and cancer guides should not be limited to oncologists. Modern oncology now spans pathology, staging, molecular biomarkers, precision medicine, prevention, surgery, radiation, chemotherapy, targeted therapy, immunotherapy, cellular therapy, cancer metabolism, treatment resistance, supportive care, and clinical research.
This OneDayMD guide brings those subjects together in one navigable resource. Rather than hundreds of disconnected articles, it offers a pathway through the evidence and links directly to deeper OneDayMD, SmartCancer, and Cancer Advisor resources.
This page is a map, not a single treatment guide — it connects the OneDayMD network's cancer content by the question you're actually asking. Newly diagnosed and want the basics? Start with the Cancer Academy. Researching prevention or lowering recurrence risk? Jump to Section 2. Deciding on treatment based on a biomarker? See Section 4. Treatment stopped working? Go straight to the Resistance Atlas. Researching repurposed drugs or integrative options? Read Section 10 together with the evidence-reading framework before discussing anything with your oncology team — case reports and preclinical data (evidence grade E0–E2) are not the same as randomized trial evidence (E4–E5).
How to use this guide: You do not need to read everything. A newly diagnosed patient may begin with the Cancer Academy and treatment sections; a patient with progression may go directly to biomarkers and treatment resistance; a reader researching prevention, metabolism, or repurposed drugs can move into those sections directly using the table of contents below.
Jump to a Section
- Start Here: Seven Cancer Research Pathways
- 1. Cancer Academy: Build the Foundation First
- 2. Cancer Prevention & Risk Reduction
- 3. Understanding Cancer Biology
- 4. Biomarkers & Precision Oncology
- 5. Standard Treatment & New Therapeutic Platforms
- 6. Immunotherapy: The Immune Treatment Revolution
- 7. Cancer Treatment Resistance
- 8. Metabolic Oncology & Cancer Metabolism
- 9. Nutrition, Diet & Supplements
- 10. Repurposed Drugs & Integrative Oncology Research
- 11. Fenbendazole, Ivermectin & Mebendazole Case-Report Research
- 12. DMSO & Other Unconventional Approaches
- 13. How to Read Cancer Evidence
- 14. Research Tools: Verify the Information Yourself
- 15. A Better Way to Research a Cancer Treatment
- 16. The OneDayMD Cancer Knowledge Graph
- 17. What This Resource Is — and Is Not
- 18. Using AI Assistants With This Guide
- Frequently Asked Questions
- Continue Your Research
Start Here: Seven Cancer Research Pathways
Cancer is not one disease. The appropriate information depends on the cancer type, stage, pathology, molecular features, previous treatment, current response and the patient's overall clinical situation. The most useful cancer research process therefore starts with the question you are trying to answer.
1. I Just Diagnosed With Cancer
Start with the basics before jumping into experimental therapies.
2. I Want to Reduce My Risk or Prevent Recurrence
Explore evidence-graded primary prevention, screening, and post-treatment risk reduction.
3. What Does My Biomarker Mean?
Move from diagnosis toward molecular and immune profiling.
4. What Treatments Are Available?
Understand the conventional treatment landscape and newer therapeutic platforms.
5. Why Did Treatment Stop Working?
Focus on tumor evolution, resistance mechanisms and new treatment strategies.
6. What About Metabolic or Integrative Oncology?
Explore metabolism and complementary research without confusing biological plausibility with proven clinical benefit.
7. I Want to Read the Research Myself
Use primary literature and clinical-trial databases to verify claims.
1. Cancer Academy: Build the Foundation First
Before evaluating a particular supplement, repurposed drug, diet or experimental therapy, establish the underlying cancer picture. That means understanding the diagnosis, histology, stage, grade, pathology report, molecular findings and previous treatment history.
Cancer Academy & Protocols Library 2026
A patient-first educational entry point covering cancer biology, diagnosis, treatment, biomarkers, evidence levels, protocols and research questions.
OneDayMD Academy
The broader OneDayMD education hub connecting cancer, nutrition, supplements, longevity, metabolic health and other health-information resources.
OneDayMD Master Oncology Guide
A systems-level framework spanning prevention, diagnosis, staging, precision oncology, treatment, immunotherapy, metabolism, resistance and survivorship.
2. Cancer Prevention & Risk Reduction
Prevention research spans two related but distinct questions: how to reduce the risk of developing cancer in the first place (primary prevention), and how to reduce the risk of recurrence after treatment (maintenance and surveillance). Both are frequently overstated online, so the same evidence discipline used elsewhere in this guide applies here.
The ROOT Protocol: Vitamin D to Ivermectin
Reviews the ROOT and I-PREVENT prevention frameworks attributed to Marik and Hope, spanning vitamin D optimization through more speculative repurposed-drug prevention strategies, with evidence grading throughout.
Cancer Prevention Supplements & Diet
Covers dietary and supplement strategies proposed for cancer risk reduction, distinguishing correcting a deficiency from using high-dose supplementation as a purported preventive treatment.
Cancer Maintenance After NED
A multi-axis metabolic and monitoring framework for patients who have reached no evidence of disease and are researching recurrence-reduction strategies.
Screening (mammography, colonoscopy, low-dose CT and similar guideline-based tests) is the most evidence-backed prevention tool available and should be discussed with a primary care physician or oncologist using current national guidelines — this guide does not replace that conversation.
3. Understanding Cancer Biology
Modern oncology increasingly integrates multiple biological layers rather than viewing cancer through a single lens. Genetics matter, but so do tumor heterogeneity, metabolism, immune surveillance, angiogenesis, the tumor microenvironment and evolutionary adaptation.
Systems Oncology
Explore cancer as an interacting network of genetics, epigenetics, metabolism, immunity, tumor microenvironment and host biology. Read the Systems Oncology Guide →
Metabolic Hallmarks
Understand glucose metabolism, mitochondrial function, lactate, hypoxia, glutamine, lipid metabolism, redox biology and metabolic flexibility. Read the Metabolic Hallmarks Guide →
Metabolic & Immune Biology
Examine the relationship between cancer metabolism, immune-cell function and the tumor microenvironment. Explore Metabolic Immuno-Oncology →
4. Biomarkers & Precision Oncology
One of the biggest changes in modern cancer care is the movement from purely anatomical classification toward molecularly informed treatment. A diagnosis such as "lung cancer" or "colorectal cancer" is often only the beginning of the treatment-selection process.
Depending on the disease, clinicians may consider genomic alterations, protein expression, mismatch-repair or microsatellite-instability status, tumor mutational burden, hormone receptors, immune biomarkers, circulating tumor DNA and other molecular characteristics.
Biomarkers in the Era of Cancer Immunotherapy
A deeper look at the interaction between tumor biology, the tumor microenvironment and immune-response biomarkers.
Systems Oncology: Measure → Model → Target → Monitor → Adapt
A broader framework for connecting biomarkers with treatment selection and longitudinal monitoring.
5. Standard Cancer Treatment & New Therapeutic Platforms
Standard cancer therapy remains the foundation of modern oncology. Depending on the disease, treatment may involve surgery, radiation therapy, chemotherapy, targeted therapy, hormone therapy, antibody-drug conjugates, immunotherapy, cellular therapy, bispecific antibodies or clinical trials.
Latest Treatment Advances
A continually updated overview of emerging developments across precision oncology, immunotherapy, targeted treatment and cellular therapy. Latest Cancer Breakthroughs 2026 →
Immunotherapy
Learn about checkpoint inhibitors, cellular therapy, monoclonal antibodies, bispecific antibodies and other immune-based approaches. Cancer Immunotherapy Guide →
Cell Therapy
Explore CAR-T, CAR-NK and other cellular platforms and the scientific questions surrounding them. CAR-T vs CAR-NK →
6. Immunotherapy: Understanding the Immune Treatment Revolution
Immunotherapy has changed the treatment landscape for many cancers. But "immunotherapy" is not a single drug or single mechanism. Response can depend on tumor biology, immune-cell infiltration, checkpoint expression, molecular characteristics and the surrounding tumor microenvironment.
Immunotherapy to Treat Cancer: Types, Benefits, Risks & Breakthroughs
Covers major immunotherapy categories and how immune-based cancer treatment fits within modern oncology.
CAR-T vs CAR-NK Cell Therapy
A comparison of two major cellular-immunotherapy platforms and the scientific questions surrounding their development.
Metabolic Oncology & Immune Metabolism
Examines how metabolism and the tumor microenvironment may interact with immune-cell function.
7. Cancer Treatment Resistance
Treatment resistance is one of the central problems in oncology. Cancer can be resistant from the outset, or it can evolve after an initial response. Mechanisms can include clonal selection, new mutations, pathway rewiring, epigenetic adaptation, drug-tolerant cell states, altered drug transport, immune escape, tumor heterogeneity and microenvironmental changes.
Cancer Treatment Resistance: Why Treatment Stops Working
Introduces the major biological and clinical mechanisms of resistance across treatment classes.
Cancer Treatment Resistance Atlas
Organizes the problem as: Cancer Type → Biomarker → Treatment → Response → Resistance → Mechanism → Resistance Biomarker → Testing → Next-Treatment Strategy.
8. Metabolic Oncology & Cancer Metabolism
Cancer metabolism is an important research field examining how malignant cells alter glucose utilization, mitochondrial function, amino-acid metabolism, lipid metabolism, redox balance and interactions with the tumor microenvironment.
The crucial distinction is between understanding a metabolic pathway and demonstrating that changing it improves outcomes in patients. A biologically attractive hypothesis still requires appropriate human evidence.
7-Layer Framework
Integrates metabolic health, nutrition, standard oncology treatment, investigational therapies, mitochondrial biology, cancer stem-cell biology, immune metabolism and lifestyle. Read the 7-Layer Framework →
Metabolic Therapy
Reviews the concepts behind metabolic interventions and the developing evidence base. Metabolic Therapy for Cancer →
Integrative Metabolic Oncology
Explores how metabolic interventions and repurposed agents may be studied alongside conventional cancer treatment. Integrative Metabolic Oncology →
9. Nutrition, Diet & Supplements
Nutrition matters throughout cancer care, but nutrition claims are frequently overstated online. A useful framework separates supporting nutritional status and metabolic health from claims that a particular food or supplement can directly treat a tumor.
Why Most "Anti-Cancer" Diet Claims Fail Clinical Testing
A critical review of common claims involving sugar restriction, ketogenic diets, fasting and other popular cancer diets.
Best Anti-Cancer Supplements: Evidence-Based Guide
A context-dependent review emphasizing evidence quality, safety and the distinction between correcting deficiencies and using high-dose supplements as purported anti-cancer treatments.
Master Guide to Nutrition, Vitamins & Supplements
The broader OneDayMD nutrition and supplement reference library.
10. Repurposed Drugs & Integrative Oncology Research
Drug repurposing is the investigation of an existing medicine for a new therapeutic purpose. In oncology, this research includes a wide range of conventional medicines and anti-infective drugs. The evidence can range from laboratory experiments to case reports, observational studies and clinical trials.
Repurposed Drugs, Integrative Cancer Care & Precision Oncology
OneDayMD's central overview of repurposed-drug research, integrative oncology, precision medicine, evidence grading, safety and regulatory considerations.
Ivermectin, Mebendazole, Atovaquone & Niclosamide for Cancer
A 2026 evidence review covering four repurposed agents and distinguishing preclinical evidence, early clinical evidence and regulatory status.
Ivermectin, Fenbendazole & Mebendazole Cancer Research Guide
Reviews the proposed mechanisms and emerging evidence surrounding three widely discussed repurposed agents.
11. Fenbendazole, Ivermectin & Mebendazole Case-Report Research
OneDayMD maintains a large archive of real-world reports involving repurposed antiparasitic agents. These pages are best understood as a research and hypothesis-generation archive, not as proof that the reported treatments caused the outcomes described. The regulatory note in Section 10 applies to this archive as well.
760+ Case Reports Archive
A large compilation organized by cancer type, including reported treatment combinations and outcomes.
Breast Cancer Case Series
A dedicated case-series compilation involving ivermectin, mebendazole and fenbendazole.
Lung Cancer Case Series
A dedicated compilation of reported cases involving fenbendazole, ivermectin and/or mebendazole.
When reading any case report or testimonial, ask:
- Was the diagnosis independently documented?
- Were imaging or laboratory outcomes objectively verified?
- What other treatments were being given at the same time?
- Could the response have resulted from standard therapy?
- Was the cancer stable, partially responsive or completely responsive?
- How long was follow-up?
- Was the report published in a peer-reviewed source or only posted online?
12. DMSO & Other Unconventional or Supportive Approaches
Some readers also investigate DMSO and other unconventional approaches for symptom management, treatment support or laboratory research. These subjects require especially careful separation of historical evidence, preclinical mechanisms, clinical studies and anecdotal claims.
DMSO for Cancer: Supportive-Care & Research Review
A OneDayMD review of the history and proposed roles of DMSO in cancer-related contexts.
The History and Safety of DMSO
Broader background on DMSO, its pharmacology, clinical history and areas of study.
13. How to Read Cancer Evidence
The same intervention can appear extremely convincing in a laboratory paper and remain unproven in patients. A resource guide therefore needs an explicit evidence-reading method.
| Evidence Type | What It Can Tell You | What It Cannot Establish Alone |
|---|---|---|
| Cell / laboratory research | Biological mechanisms and whether a pathway may be affected under experimental conditions. | Clinical benefit, appropriate human dose, long-term safety or survival benefit. |
| Animal studies | Provides biological and pharmacological evidence in an organism. | That the same effect will occur in humans. |
| Case reports / testimonials | Signals worth investigating and unusual clinical observations. | Causation, average treatment effect or general effectiveness. |
| Retrospective / observational studies | Associations, real-world outcomes and potential safety signals. | May still be affected by confounding, selection bias and treatment differences. |
| Randomized controlled trials | More reliable evidence about comparative treatment effects when well designed and adequately powered. | That every patient or cancer type will respond the same way. |
| Systematic reviews / meta-analyses | Can synthesize multiple studies and assess consistency. | Cannot repair major weaknesses or bias in the underlying evidence. |
A useful rule is simple: the more consequential the medical decision, the more important it is to prioritize high-quality, disease-specific human evidence.
| Grade | Evidence Level | Interpretation |
|---|---|---|
| E5 | Strong clinical evidence / guideline-supported | Established or strongly supported clinical relevance |
| E4 | Prospective clinical evidence | Meaningful human evidence, although not necessarily universal standard of care |
| E3 | Retrospective or substantial human evidence | Clinically informative but subject to important limitations and confounding |
| E2 | Case reports / small observational evidence | Hypothesis-generating rather than proof of efficacy |
| E1 | Preclinical evidence | Laboratory or animal evidence requiring clinical validation |
| E0 | Hypothesis / mechanistic speculation | Not clinically established |
This E0–E5 scale is used consistently across the network's repurposed-drug, resistance, and protocol content, including the Resistance Atlas and the SmartCancer Directory, so evidence grades carry the same meaning wherever you encounter them.
14. Research Tools: Verify the Information Yourself
OneDayMD is designed to help readers understand complex topics and find relevant research. The next step is to verify important claims against primary and authoritative sources.
PubMed
Search biomedical publications by drug, biomarker, cancer type, study design or author. Search PubMed →
ClinicalTrials.gov
Search registered clinical studies, interventions, eligibility criteria and trial status. Search Clinical Trials →
National Cancer Institute
Access government cancer information covering diagnosis, treatment, clinical trials and supportive care. Visit Cancer.gov →
FDA
Verify U.S. drug approvals, labeling and regulatory information. FDA Drug Information →
15. A Better Way to Research a Cancer Treatment
When investigating a new treatment, supplement or repurposed drug, use a structured sequence rather than searching the internet for success stories.
- Define the cancer precisely: cancer type, subtype, stage, grade and disease location.
- Identify important biomarkers: genomic, immune, pathological and other clinically relevant findings.
- Map current treatment: what has already been tried, what worked and what stopped working.
- Identify the treatment goal: cure, disease control, symptom relief, preventing recurrence or another objective.
- Search human evidence first: prioritize disease-specific trials and clinically relevant studies.
- Use mechanistic evidence second: mechanisms can explain why an approach is being studied, but they do not prove clinical efficacy.
- Check interactions and safety: especially when combining supplements, repurposed drugs or experimental therapies with standard treatment.
- Look for resistance mechanisms: progression may require a new biological assessment rather than simply adding another drug.
- Discuss the evidence with the oncology team: especially before changing prescribed treatment or adding an off-label intervention.
16. The OneDayMD Cancer Knowledge Graph
The goal of this resource page is not merely to create another long list of articles. It is to connect cancer information into a navigable knowledge graph.
| Layer | Core Question | Primary OneDayMD Resource |
|---|---|---|
| Cancer Biology | What is happening biologically? | Systems Oncology |
| Diagnosis | What exactly is the cancer? | Cancer Academy |
| Prevention | How can risk or recurrence be reduced? | ROOT Protocol & Prevention Framework |
| Biomarkers | What molecular or immune features matter? | Cancer Biomarkers |
| Treatment | What therapies are available? | Latest Treatment Breakthroughs |
| Immunotherapy | Can the immune system be targeted? | Immunotherapy Guide |
| Resistance | Why did treatment stop working? | Resistance Atlas |
| Metabolism | How does metabolism interact with cancer? | 7-Layer Metabolic Oncology |
| Repurposed Drugs | What existing drugs are being investigated? | Repurposed Drugs Hub |
| Nutrition | How can diet and nutritional status be evaluated? | Nutrition & Supplements Master Guide |
| Research | What does the published evidence show? | PubMed |
17. Important Distinctions: What This Resource Is — and Is Not
This guide is designed to make cancer information easier to navigate. It is not a substitute for pathology review, staging, molecular testing, multidisciplinary oncology assessment or individualized medical advice.
OneDayMD discusses both established and investigational subjects because patients frequently encounter both categories during their research. Presenting an investigational therapy here does not mean that it has been established as effective, safe, or appropriate for every patient.
18. Using AI Assistants With This Guide
Readers increasingly bring cancer questions to AI chat tools before or alongside searching the web. This guide is structured so that an AI assistant can accurately summarize and cite it. If you're using one of the tools below to research your own situation, a few practices make the answers more useful and safer.
| Tool | How to use it with this guide |
|---|---|
| Claude | Paste your specific diagnosis, stage and biomarker details along with a link to the relevant section (e.g., the Resistance Atlas) and ask it to map your situation against the evidence-grading framework in Section 13 before discussing findings with your oncologist. |
| ChatGPT | Ask it to separate any answer into "established standard of care" versus "investigational or preclinical" using the E0–E5 scale in Section 13, and to flag when a claim rests only on case reports. |
| Gemini | Useful for pulling recent primary literature alongside this guide's links — ask it to check publication dates against the "last reviewed" date on this page, since oncology evidence changes quickly. |
| Perplexity | Good for verifying a specific claim (a trial result, an approval date, a regulatory notice) against primary sources cited inline, rather than relying on this guide's summary alone. |
Frequently Asked Questions
What is the best place to start researching cancer?
Start with the exact diagnosis, stage and pathology, then move to relevant biomarkers and evidence-based treatment options. The Cancer Academy provides a structured starting point before moving into more specialized topics.
Does this guide cover cancer prevention?
Yes. Section 2 covers primary prevention, risk reduction and post-treatment maintenance, including the ROOT and I-PREVENT frameworks, separately from the treatment-focused sections of the guide.
Is there a regulatory notice on repurposed drugs like ivermectin and fenbendazole?
Yes. ASCO issued a Clinical Notice in May 2026 advising against ivermectin and fenbendazole for cancer outside of a clinical trial. This is discussed in Section 10 alongside the case-report archive in Section 11, and should be reviewed before considering off-label use.
Why does OneDayMD discuss experimental and repurposed cancer therapies?
Patients actively search for these subjects, particularly when standard treatment has stopped working or when a cancer is difficult to treat. The purpose of covering them is to organize the research, explain what is known, identify evidence gaps and distinguish hypothesis-generating observations from established treatment.
Are case reports proof that a cancer treatment works?
No. Case reports and testimonials can identify interesting observations and generate hypotheses, but they do not control for other treatments, patient selection, natural disease variation or other forms of confounding. Stronger evidence generally comes from appropriately designed human clinical studies.
Why are biomarkers important?
Some treatments work only in particular biological contexts. Molecular and immune biomarkers can help identify patients who may be more likely to benefit from a specific therapy, while other biomarkers may help explain resistance.
Does metabolic oncology replace conventional cancer treatment?
No. The OneDayMD framework treats metabolic oncology as a complementary research field rather than a replacement for evidence-based tumor-directed treatment. The 7-Layer Metabolic Oncology Framework explains this distinction in more detail.
Where can I check whether a cancer therapy is being studied in a clinical trial?
Search ClinicalTrials.gov by cancer type, drug name, biomarker or intervention. Published biomedical research can be searched through PubMed.
Why might cancer return after successful treatment?
Recurrence can result from residual disease, resistant cell populations, molecular evolution, treatment selection and other biological processes. The Cancer Treatment Resistance Atlas organizes these mechanisms into a practical research framework.
Continue Your Research
The most useful cancer information is rarely found on one page. Think of this guide as the front door to a larger research system — and one of three related network hubs, each with a different purpose:
- This page (Cancer Resources & Research Guide) is the top-level map across all three properties, organized by the question you're asking.
- The Cancer Academy & Protocols Library is the structured patient-education curriculum for understanding a new diagnosis.
- The Directory: Cancer Protocols, Metabolic & Precision Oncology Library is the detailed protocol and case-series reference library.
If you're not sure which one you need: start here for orientation, use the Academy to learn the fundamentals of your diagnosis, and use the Directory when you're ready to go deep on a specific protocol or evidence base.
Then follow the question that matters most: biomarker → treatment → response → resistance → next strategy.
For readers researching integrative or emerging approaches, continue through the metabolic oncology, repurposed-drug, nutrition and real-world evidence sections while keeping the distinction between what is biologically plausible, what has been observed and what has been demonstrated in well-designed human studies.
OneDayMD Editorial Team
Independent health information, evidence review and research navigation.
Published: September 17, 2026 · Last reviewed and updated: September 18, 2026
Editorial principle: Empower, don't influence. The goal is to make health information accessible, transparent and easier to investigate — without gatekeeping the research or presenting investigational approaches as established medical care.
.png)
.png)
Comments
Post a Comment